NAFLD study in Chinese patients having obesity surgery
Part of Digestive system clinical trials.
This study follows Chinese patients who are having obesity surgery to understand how nonalcoholic fatty liver disease (NAFLD) changes over time and to find markers that might predict its course. It could help doctors better treat liver problems in people with obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are of Chinese ethnicity
- You are scheduled for obesity surgery at The Prince of Wales Hospital
- Your obesity is not caused by a hormone disorder
- You do not have an active, uncontrolled psychiatric illness or substance abuse problem
- You do not drink more than about 2 standard drinks per day (men) or 1.5 drinks per day (women)
- You do not have other liver diseases (like hepatitis B or C) or a history of severe liver damage
- You are willing to follow the study's guidelines and give your consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a long-term study that follows adults who are being managed for fatty liver (NAFL) or NASH to learn how these conditions change over time. It may help researchers better understand what to expect and how care decisions could be improved.
This study compares high-intensity exercise to moderate-intensity exercise to see which is better at reducing fat in the liver for people with obesity and fatty liver disease.
This study follows people who have chronic hepatitis B and also have fat buildup in the liver (nonalcoholic fatty liver disease). It’s looking at how these conditions behave over time and what may help, using information collected during follow-up visits.
This study follows people with fatty liver disease (NAFLD) and a related condition (NASH) to see how it changes over time. It may help researchers understand who is most likely to worsen and what patterns show up as the disease progresses.
This study measures different fats and proteins in the liver of people with fatty liver disease (often called NAFLD) who are having planned abdominal or weight-loss surgery. It may help doctors better understand what’s happening in the liver and improve future care.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
Hear when a new Nonalcoholic Fatty Liver Disease (NAFLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.